Hong Mak
Registered Nurse · Brooklyn, NYNPI 1437568383
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Gilead at 36.0% of the total. Among registered nurse clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $40.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$824
- Phathom Pharmaceuticals, Inc.$250
- AstraZeneca$201
- Johnson & Johnson$149
- Exelixis Inc.$135
- Stemline Therapeutics Inc.$125
- plus $603 from 14 others
What the payments were for
- Food & beverage$2,287100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 18 | $824 |
| Phathom Pharmaceuticals, Inc. | 2 | $250 |
| AstraZeneca | 5 | $201 |
| Johnson & Johnson | 5 | $149 |
| Exelixis Inc. | 1 | $135 |
| Stemline Therapeutics Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $105 |
| Bayer | 3 | $92 |
| GSK | 3 | $74 |
| Deciphera Pharmaceuticals Inc. | 2 | $49 |
| Agios Pharmaceuticals, Inc. | 2 | $45 |
| Blueprint Medicines Corporation | 1 | $36 |
| Syndax Pharmaceuticals, Inc. | 2 | $33 |
| Eisai Inc. | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Genmab U.S., Inc. | 1 | $28 |
| Puma Biotechnology, Inc. | 1 | $24 |
| Novartis | 1 | $22 |
| Servier Pharmaceuticals LLC | 1 | $19 |
| Pfizer | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,287 in reported general payments places this provider in the 95th percentile of 446 registered nurse providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 67 | $1,373 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 34 | $1,346 |
| Morphine Sulfate ErMorphine Sulfate | 19 | $573 |
| Pregabalin | 14 | $442 |
| Hydromorphone Hcl | 25 | $323 |
| Gabapentin | 17 | $288 |
| Lorazepam | 12 | $192 |
| Clonazepam | 19 | $166 |
| Zolpidem Tartrate | 11 | $121 |
| Warfarin Sodium | 11 | $67 |
Paid to pharmacies, not to this prescriber.
Other registered nurse in Brooklyn
- Oddette JosephsBrooklyn$2K
- Robert CainBrooklyn$2K
- Kaia EvansBrooklyn$2K
- Angela MedinaBrooklyn$1K
- Johanne HilaireBrooklyn$843
- Shahruma IslamBrooklyn$643
- Sandra FrancisBrooklyn$488
- Jane SeleyNew York$20K
- Chia-Wei LinBronx$15K
- Cathleen VarleyNew York$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.